Outcome of asthma: longitudinal changes in lung function

Current knowledge about factors determining outcome of asthma is limited, but observations over the last few decades suggest that active asthma has a negative impact on the longitudinal changes in lung function. This review aims to give an overview of the present knowledge concerning longitudinal changes in lung function, including clinical markers for distinctly poor outcome with regard to lung function, in children and adults suffering from asthma. The majority of patients with asthma have a good prognosis. However, some patients with asthma, especially those with more severe disease, are at risk of impaired growth of lung function during childhood, a lower maximally attained level of lung function and excessive decline in lung function in adulthood, which may lead to life-threatening lung function impairment. Clinical markers of poorly controlled airway inflammation appear to have a negative impact on the longitudinal changes in lung function, and disease progression to nonreversible airflow obstruction may be observed in a minority of patients with asthma. Early intervention with anti-inflammatory therapy may improve the short-term outcome of asthma, but long-term controlled studies are clearly needed in order to verify whether or not treatment, especially with inhaled corticosteroids, according to the current international guidelines alters the natural history of asthma, i.e. disease progression with regard to changes in lung function and possible development of nonreversible airflow obstruction.

This article has been cited by other articles:

				D. R. Taylor, E. D. Bateman, L-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, J. C. de Jongste, et al. A new perspective on concepts of asthma severity and control Eur. Respir. J., September 1, 2008; 32(3): 545 - 554. [Abstract] [Full Text] [PDF]

				I. H. van Veen, A. ten Brinke, P. J. Sterk, J. K. Sont, S. A. Gauw, K. F. Rabe, and E. H. Bel Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Eur. Respir. J., August 1, 2008; 32(2): 344 - 349. [Abstract] [Full Text] [PDF]

				P. Subbarao and M. R Sears The chicken or the egg? Perhaps the egg Arch. Dis. Child., July 1, 2008; 93(7): 552 - 553. [Full Text] [PDF]

				A. L. James and S. Wenzel Clinical relevance of airway remodelling in airway diseases Eur. Respir. J., July 1, 2007; 30(1): 134 - 155. [Abstract] [Full Text] [PDF]

				P Lange, H Scharling, C S Ulrik, and J Vestbo Inhaled corticosteroids and decline of lung function in community residents with asthma Thorax, February 1, 2006; 61(2): 100 - 104. [Abstract] [Full Text] [PDF]

				P. K. Henneberger, A.-C. Olin, E. Andersson, S. Hagberg, and K. Toren The Incidence of Respiratory Symptoms and Diseases Among Pulp Mill Workers With Peak Exposures to Ozone and Other Irritant Gases Chest, October 1, 2005; 128(4): 3028 - 3037. [Abstract] [Full Text] [PDF]

				M. R. Sears, J. M. Greene, A. R. Willan, E. M. Wiecek, D. R. Taylor, E. M. Flannery, J. O. Cowan, G. P. Herbison, P. A. Silva, and R. Poulton A Longitudinal, Population-Based, Cohort Study of Childhood Asthma Followed to Adulthood N. Engl. J. Med., October 9, 2003; 349(15): 1414 - 1422. [Abstract] [Full Text] [PDF]

				F. Cibella, G. Cuttitta, V. Bellia, S. Bucchieri, S. D'Anna, D. Guerrera, and G. Bonsignore Lung Function Decline in Bronchial Asthma Chest, December 1, 2002; 122(6): 1944 - 1948. [Abstract] [Full Text] [PDF]

				J. de Kluijver, C. E. Evertse, J. A. Schrumpf, H. van der Veen, A. H. Zwinderman, P. S. Hiemstra, K. F. Rabe, and P. J. Sterk Asymptomatic Worsening of Airway Inflammation during Low-Dose Allergen Exposure in Asthma: Protection by Inhaled Steroids Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 294 - 300. [Abstract] [Full Text] [PDF]

				A. L. Kozyrskyj, C. A. Mustard, and F. E. R. Simons Socioeconomic Status, Drug Insurance Benefits, and New Prescriptions for Inhaled Corticosteroids in Schoolchildren With Asthma Arch Pediatr Adolesc Med, November 1, 2001; 155(11): 1219 - 1224. [Abstract] [Full Text] [PDF]

				A. L. Kozyrskyj, C. A. Mustard, M. S. Cheang, and F. Simons Income-based drug benefit policy: impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthma Can. Med. Assoc. J., October 1, 2001; 165(7): 897 - 902. [Abstract] [Full Text] [PDF]

				A. ten BRINKE, A. H. ZWINDERMAN, P. J. STERK, K. F. RABE, and E. H. BEL Factors Associated with Persistent Airflow Limitation in Severe Asthma Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 744 - 748. [Abstract] [Full Text] [PDF]

				I. D. BIJL-HOFLAND, S. G. M. CLOOSTERMAN, H. Th. M. FOLGERING, F. J. J. van den ELSHOUT, C. van WEEL, and C. P. van SCHAYCK Inhaled Corticosteroids, Combined with Long-acting beta 2-Agonists, Improve the Perception of Bronchoconstriction in Asthma Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 764 - 769. [Abstract] [Full Text] [PDF]

				S. H. DOWNS, T. Z. MITAKAKIS, G. B. MARKS, N. G. CAR, E. G. BELOUSOVA, J. D. LEUPPI, W. XUAN, S. R. DOWNIE, A. TOBIAS, and J. K. PEAT Clinical Importance of Alternaria Exposure in Children Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 455 - 459. [Abstract] [Full Text] [PDF]

				Y.-F. LI, F. D. GILLILAND, K. BERHANE, R. MCCONNELL, W. JAMES GAUDERMAN, E. B. RAPPAPORT, and J. M. PETERS Effects of In Utero and Environmental Tobacco Smoke Exposure on Lung Function in Boys and Girls with and without Asthma Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2097 - 2104. [Abstract] [Full Text]

				R. WOLFE, J. B. CARLIN, H. OSWALD, A. OLINSKY, P. D. PHELAN, and C. F. ROBERTSON Association Between Allergy and Asthma from Childhood to Middle Adulthood in an Australian Cohort Study Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2177 - 2181. [Abstract] [Full Text]

				P. PAREDI, S. A. KHARITONOV, and P. J. BARNES Elevation of Exhaled Ethane Concentration in Asthma Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1450 - 1454. [Abstract] [Full Text] [PDF]